RS
Tevogen Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TVGN-489 | COVID-19 (Acute Infection) | Phase 1/2 |
| ExacTcell Platform | Viral-Induced Cancers | Discovery/Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| TVGN-489 | COVID-19 (Acute Infection) | Phase 1/2 |
| ExacTcell Platform | Viral-Induced Cancers | Discovery/Preclinical |